ABL1 and Insulin resistance: Racil et al suggested that peripheral insulin resistance is mediated by c-Abl inhibition which is involved in insulin receptor signaling (Fig. 2).67This hypothesis is contrary to the hypothesis described with dasatinib and imatinib in which c-Abl enhances insulin sensitivity through c-Abl inhibition.